ロード中...
Management of newly diagnosed immune thrombocytopenia: can we change outcomes?
Immune thrombocytopenia resulting from antibody-mediated platelet destruction combined with impaired platelet production is a common cause of thrombocytopenia. The decision to treat newly diagnosed patients is based on several factors including ceasing hemorrhagic manifestations, increasing the plat...
保存先:
| 出版年: | Hematology Am Soc Hematol Educ Program |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Hematology
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6142545/ https://ncbi.nlm.nih.gov/pubmed/29222284 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|